| Financial Year |
March 31 2023 |
| Monetary Funds |
1,083,467,427.60 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
973,434,710.32 |
| Advances to Suppliers |
88,115,570.45 |
| Other Receivables |
1,024,754,889.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,758,013,913.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
74,183,289.05 |
| Total Current Assets |
5,001,969,800.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,071,046,955.60 |
| Investment Properties |
15,027,114.88 |
| Fixed Assetes |
3,375,711,948.31 |
| Under-construction Projects |
454,331,415.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
2,054,838,302.56 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
389,959,142.05 |
| R&D expenses |
-- |
| Goodwill |
19,658,150.77 |
| Long-Term Deferred and Prepaid Expenses |
166,917,163.77 |
| Deferred Income Tax Assets |
59,447,422.89 |
| Other Non-Current Assets |
27,675,502.41 |
| Sub-Total of Non-Current Assets |
9,624,766,362.72 |
| Total Assets |
14,626,736,163.34 |
| Short-Term Loans |
2,025,553,678.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,047,265,855.52 |
| Accounts Received In Advance |
4,346,214.08 |
| Employee Compensation Payable |
136,315,555.33 |
| Taxes Payable |
71,382,068.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,364,019,489.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
204,008,282.02 |
| Other Current Liabilities |
14,907,499.45 |
| Sub-Total of Current Liabilities |
5,138,766,142.52 |
| Long-term Loans |
2,059,651,295.62 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
49,928,875.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,520,280.00 |
| Deferred Income Tax Liabilities |
27,996,588.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,358,612,841.34 |
| Total Liabilities |
8,497,378,983.86 |
| Paid-In Capital(Or Share Stock) |
1,519,110,426.00 |
| Capital Surplus |
3,004,880,396.92 |
| Surplus Reserve |
143,121,253.75 |
| LESS:Treasury Stock |
64,199,280.00 |
| Undistributed Profits |
431,700,586.24 |
| Minority Stockholder's Interest |
1,114,377,722.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,014,979,456.75 |
| Owner's Equity（Stockholder's Equity） |
6,129,357,179.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,626,736,163.34 |
